OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).

OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.

Indexing: DOAJ-Directory of Open Access Journals.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 7.5 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period).

Free Publication in 2020
Current Issue: 2020  Archive: 2019 2018 2017
Open Access Case Report
Behavioral Disorders and Celiac Disease: Coincidence or Casualty?

Cristóbal Coronel-Rodríguez 1, *, Alejandro Rodríguez-Martínez 2, *

  1. Centro de Salud "Amante Laffón", Seville, Spain

  2. Sección de Gastroenterología, Hepatología y Nutrición Pediátrica, Hospital Universitario Virgen del Rocío, Seville, Spain

Correspondence: Cristóbal Coronel-Rodríguez and Alejandro Rodríguez-Martínez

Academic Editor: Luis Rodrigo

Special Issue: Gluten-Related Neurological Disorders

Received: May 10, 2020 | Accepted: July 17, 2020 | Published: July 24, 2020

OBM Neurobiology 2020, Volume 4, Issue 3, doi:10.21926/obm.neurobiol.2003067

Recommended citation: Coronel-Rodríguez C, Rodríguez-Martínez A. Behavioral Disorders and Celiac Disease: Coincidence or Casualty?. OBM Neurobiology 2020;4(3):9; doi:10.21926/obm.neurobiol.2003067.

© 2020 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Abstract

This paper presents the case of a child diagnosed with both celiac disease and Asperger’s syndrome. The literature does not report this association to date, and the authors believe it to be a coincidence rather than a casualty.

Keywords

Celiac disease; child; Asperger’s syndrome; autism spectrum disorder

1. Introduction

The earliest descriptions of gluten-related neurological disorders date back to the 1960s. Gluten ataxia is the most widely known and studied disorder, although other highly specific neurological manifestations such as peripheral neuropathy, celiac disease, epilepsy, or cerebral calcifications syndrome have also been described. These particular manifestations are infrequent in children and, contrary to that in adults, other less specific associations such as headaches, behavioral disorders, or autism have been described [1,2].

Celiac disease (CD) is one of the most common chronic digestive disorders. Clinical features of CD differ significantly depending on the age of presentation. Infantile CD usually appears as a classic form and is characterized by a predominance of digestive symptoms (typical malabsorption syndrome with weight loss, profuse diarrhea, and signs of nutritional and vitamin deficiencies). On the other hand, CD in older children, adolescents, and young adults tends to appear in a silent form, with fewer digestive symptoms and frequent extraintestinal manifestations, along with many associated diseases, thus making it extremely difficult to diagnose. Neurological and psychiatric symptoms are probably the least popular clinical conditions of all [3].

Hadjivassiliou et al. [5] established that gluten-related neurological disorders that appear in childhood (headaches, hypotonia, learning, and behavioral disorders, delayed psychomotor development, epilepsy) tend to respond better to a gluten-free diet (GFD); the earlier this approach is initiated, the more efficient are the results. Some symptoms disappeared entirely with the commencement of GFD, while at times, the symptoms worsened after food ingestion [5]. These circumstances are, however, less frequent in adults. Once CD has been diagnosed, and dietary treatment with GFD has been initiated, the risk of developing neurological or psychiatric disorders is low in children, which is approximately 2.6%, compared to 26% in adults [6]. This discrepancy may be due to the early elimination of gluten in child patients (children are exposed to gluten for lesser time) compared to adults with considerably delayed diagnosis and hence, a prolonged active-CD [1].

Psychiatric and psychological disorders in CD have been described for years [7] and are evident in up to one-third of all celiac patients [8]. Daynes et al. [9] in the 1950s introduced the term ‘pre-celiac syndrome’ to refer to personality, cognitive, and behavioral disorders in children with celiac diseases presenting as irritable, indifferent, inappropriate behavior, and apathy [5]. Other manifestations, including depression in association with CD, is more frequently described in adults [10,11]. The association of CD with attention-deficit hyperactivity disorder (ADHD), autism, and other neurodevelopment disorders have also been described [6]. Asperger's syndrome (AS), a neurodevelopment disorder, forms a part of the autism spectrum disorders. Patients with AS face difficulties in social interactions, verbal and non-verbal communication, and may display behavioral oddities, with stereotypes and limited interests. Nevertheless, such patients do not demonstrate language delay and their cognitive development is not marked by an overall delay, but by specific impairments in certain areas. The differing clinical presentations vary according to the age and psychiatric comorbidities of patients [12].

2. Case Report

An eight year old boy presenting with behavioral disorders from an early age (12 months) reported to the author’s clinic. The disobedient patient did not respond to scolding, warnings, threats, rewards, or punishments. The parents reported these outbursts as tantrums that had only increased since the birth of a sister two years ago.

Family History: The patient’s mother was 36 years old and was undergoing levothyroxine treatment for hypothyroidism. She reported an uneventful gestation, birth, and breastfeeding period. The father of the patient was 34 years old and was insulin-dependent.

Diet History: The patient’s mother reported mixed breastfeeding from birth to five months, followed by milk formula exclusively. Gluten was introduced at six months. The patient received all immunizations as per the schedule.

At the age of 30 months, the patient’s behavioral disorders exacerbated with frequent nocturnal awakenings for no apparent reason, persistent mouth sores with constant anorexia, and severely marked eye bags. The symptoms were deliberated to be the consequence of an oppositional defiant disorder, and pathological jealousy attributed to a possibly decreased attention on the child after the birth of the younger sibling. The growth curve was normal (p75-p90) for weight and height according to standards by Fernandez et al., 2011 (WHO 2006/2007).

Chronic diarrhea was considered after noticing changes in the stools (increased number of feces, reduced consistency, and intense smell). The laboratory results indicated very high levels of IgA anti-gliadin antibodies (>80 IU/mL, normal <10) and IgA anti-transglutaminase antibodies (>80 IU/mL, normal <10). The liver profile was found to be normal. The blood biochemistry demonstrated ferritin 6 mcg/L (30-400), Hb 97 g/L (130-160), Hematocrit 0.39 (0.39-0.49), while peripheral blood smear confirmed microcytic-hypochromic anemia compatible with iron deficiency anemia. The remaining blood biochemistry appeared normal, specific IgE to food antigens, stool culture, and parasite study in feces (in 3 different samples) were identified to be negative. Oral iron supplementations were initiated. Celiac disease was suspected, and the patient was referred to the Pediatric Gastroenterology Unit.

The previous analysis was repeated in the Pediatric Gastroenterology Unit for confirmation of the results (Table 1), which highlighted strongly positive anti-endomysium antibodies and positive HLA-DQ2 and HLA-DQ8. Confirmatory diagnosis of celiac disease was established without the need for an intestinal biopsy as per the ESPGHAN 2012 criteria [13].

Table 1 Initial lab analysis at diagnosis.

The evolution of the celiac disease in the patient was favorable; the patient was monitored every 4-6 months during the first year. The analytical parameters normalized after ten months of follow-up (Figure 1) and persisted in the subsequent annual checkups.

Click to view original image

Figure 1 Transglutaminase and Serum Ferritin Levels.

IgA transglutaminase levels in the patient’s parents and sister (at age six years) were studied and were found to be normal.

Due to persistent behavioral disorders, the child was referred to a psychiatrist at the age of six. The patient met the criteria of hyperactivity (without attention-deficit) at school and home. He was very restless and disobedient as compared to his peers. High ability traits were also identified in the patient: he could read and write, identify numbers, and perform calculations well ahead of his peers. The patient disobeyed his teacher and parents. The child presented with language skills and behaved more maturely than his peers. He had a fixation on various subjects, one of which was stickers.

The Children's Mental Health Unit diagnosed the patient with AS. Though the patient was exceptionally gifted, he did not control his emotions well and did not grasp irony or double meanings. He probably violated orders at school and those by parents, mainly because he could not accept a change to rules, as he did not understand sudden changes in his routine. The child lacked empathy for his peers and was unaware of any botheration or hurt he caused to them since he was emotionally immature.

At present, the patient is undergoing treatment for tantrum control, and parents have been asked to ignore his issues. He is increasing his autonomy for daily activities like bathing and eating, and the parents are gradually expanding his responsibility in those aspects as scheduled. The patient and family members are helped to accept the disorder, to avoid behavioral problems while recognizing that the child is immature for his age. It is essential to expose the child to situations that he can understand and discuss. The patient adheres to GFD at home but not in social events, and therefore the family is limiting his social life.

The current diagnoses include hyperactivity disorder without attention-deficit, high cognitive abilities simulating Asperger syndrome, and celiac disease.

The patient is currently being followed up at the Pediatric Gastroenterology Unit and a child psychologist. Although there is a significant improvement, the child continues to display the same psychological characteristics.

3. Discussion

CD shows a classical presentation in children with digestive symptoms, and rarely, with extra-digestive symptoms of a neurological or psychological nature. The most frequently reported traits of these children include a change in character, sadness, and indifference to stimuli, or irritation. However, the only accepted criteria for an established diagnosis of CD are the morphological alterations of the mucosa of the small intestine, the presence of antibodies characteristic of the disease, and the disappearance of these alterations with the withdrawal of gluten from diet [7,13].

Extraintestinal manifestations are often not considered in the pediatric diagnosis of CD, especially if these manifestations are psychological or psychiatric. On the contrary, in adult patients, specific neurological diseases can be diagnosed and associated with CD.

The etiopathogenesis of these neurological and psychiatric disorders is largely unknown. Different potential mechanisms have been described: a particular way of reacting to infection, the presence of toxin-induced alterations in a more permeable intestinal mucosa, the direct effect of autoimmunity on the nervous system (it is known that anti-gliadin and anti-transglutaminase antibodies can be directly or indirectly neurotoxic), the existence of vasculitis associated with the presence of vitamin deficiencies (folic acid, thiamine, pyridoxine, vitamin B12, vitamin E, biopterin deficiency), to name a few [14,15,16].

The scarce data, both, for and against each of these arguments, could not yet make a clarification on the origin of the neurological and psychiatric variations [17]. The vital role of serotonin or other neurotransmitters in the development of this disorder has also not been ruled out. Altered production of certain neurotransmitters is well-known in CD and several other pathologies with psychiatric or psychological manifestations [7]. The changed production can perhaps explain the alteration of the neuronal networks involved in mood and support fact that the use of pyridoxine supplements may lessen the depressive symptoms or mood changes seen in some CD patients [17].

Episodes of increased anxiety, easy irritability, and greater asthenia have been described more frequently in celiac patients, similar to the findings in depressed individuals [18]. This symptomatology generally disappears completely after the establishment of GFD in children and adolescents, whereas adults usually require associated pharmacological treatment such as antidepressants, antipsychotics, or anxiolytics. The recurrence of symptoms, including tension, irritability, dysthymia, and even loss of concentration, has been described after the accidental or voluntary consumption of gluten [18].

From a psychopathological reference, psychiatric and personality disorders like depression or obsessive neurosis have frequently been described in both adults and children exhibiting CD [7]. Kozlowska et al. [19] described the presence of psychiatric symptoms in half of the 41 celiac children, of which 22% were free of symptoms after dietary treatment.

In the present case, the two significant diagnoses that arise are ADHD and AS, considering the lesser specific manifestations.

The association between CD and ADHD is not clear. In a review article by Martínez-Bermejo et al. on patients with CD and ADHD, it was reported the presence of ADHD symptoms in 6.8% of patients in a cohort of celiac patients [8]. This reported prevalence is similar to that of other population groups. This study established that hyperkinesia symptoms were seen in all patients by the age of one, and all of them presented attention-deficit, hyperactivity, low tolerance to frustration, impulsivity, and emotional liability [8].

Although it is assumed that the etiopathogenesis of ADHD and CD, links genetic and biological factors [7], the association between both the entities is not yet clear [4]. Most patients (up to 74%) with previously unrecognized and untreated CD, noted a considerable relief in their ADHD symptoms after six months of GFD in two recent studies by San Mauro Martín et al. [20] and Jackson et al. [21].

To date, no studies have explained the relationship between AS and CD. Though, the association between autism and CD has been mentioned previously; there is some controversy about the exact correlation between both these entities. Pavone et al. [22] studied 120 celiac patients, and none of them was autistic. Ludvigsson et al. [20] did not find any association between CD or intestinal inflammation and autism, although a marked increase in the risk of autism was observed in patients with positive serological tests but normal mucosa [23]. On the other hand, Lau et al. [24] found elevated anti-gliadin antibodies in autistic children with gastrointestinal symptoms, without any other data suggestive of CD. More studies are, therefore, warranted to establish the exact relationship between both entities [7].

Since there is no scientific basis confirming the association between autism and CD, it is not justifiable to start with a GFD in every child with autism. However, a thorough examination and clinical study must be carried out in the search for specific antibodies or enteropathy, since, in the event of a definite diagnosis, GFD will be essential and will probably improve some of the symptoms [25]. In cases with negative histological findings and high suspicion, an investigation for HLA-DQ2 and HLA-DQ8 haplotypes can be carried out, since their negativity excludes the diagnosis [13].

Concerning the association of AS and ADHD, both entities are usually diagnosed between four and eleven years of age and require a comprehensive evaluation that includes a multidisciplinary clinical team for an accurate diagnosis. The similarity in the age of presentation of both these entities leads to a misdiagnosis of AS for ADHD in many children.

In the present case, it is deliberated that the presence of CD and AS is more a result of coincidence and not a matter of chance since it is an association that has never been described earlier. Only extremely isolated cases within a broader study group have been described [26], and the behavioral improvements that would be expected after the initiation of GFD have not yet been proven.

The results of a systematic review and meta-analysis performed by Clappison et al. [27] support the idea that CD is associated with an increased risk for specific psychiatric disorders and has been linked with other developmental disorders like depression, anxiety, eating disorders, and ADHD [27]. These data hint at the importance of regular screening for CD in young patients with these types of mental illnesses [28]. However, more research is needed to investigate the pathophysiology of such associations, and the effects that the gluten-free diet could have on these conditions.

Author Contributions

C.C. conceived the original idea. C.C. took the lead in writing the manuscript. Both C.C. and A.R. authors provided critical feedback and helped shape the review, analysis and manuscript.

Competing Interests

The authors have declared that no competing interests exist.

References

  1. Trovato CM, Raucci U, Valitutti F, Montuori M, Villa MP, Cucchiara S, et al. Neuropsychiatric manifestations in celiac disease. Epilepsy Behav. 2019; 99: 106393. doi:10.1016/j.yebeh.2019.06.036 [CrossRef]
  2. Ruggieri M, Incorpora G, Polizzi A, Parano E, Spina M, Pavone P. Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity. J Pediatr. 2008; 152: 244-249. doi:10.1016/j.jpeds.2007.06.042 [CrossRef]
  3. Rodrigo Sáez L, Fuentes Álvarez D, Pérez Martínez I, Álvarez Mieres N, Niño García P, Francisco García RD, et al. Differences between pediatric and adult celiac disease. Rev Esp Enferm Dig. 2011; 103: 238-243. doi:10.4321/S1130-01082011000500003 [CrossRef]
  4. Hadjivassiliou M, Duker AP, Sanders DS. Gluten-related neurologic dysfunction. Handb Clin Neurol. 2004; 120: 607-619. doi:10.1016/B978-0-7020-4087-0.00041-3 [CrossRef]
  5. Bermejo Velasco PE, Burgos GA. Neurological complications of celiac disease. Med Clin (Barc). 2006; 127: 500-507. doi:10.1157/13093268. [CrossRef]
  6. Ertürk E, Wouters S, Imeraj L, Lampo A. Association of ADHD and celiac disease: What is the evidence? A systematic review of the literature. J Atten Disord. 2020; 24: 1371-1376. doi:10.1177/1087054715611493. [CrossRef]
  7. Martinez Bermejo A. Enfermedad celíaca. Alteraciones neurológicas y psiquiátricas. Bol Pediatr. 2009; 49: 146-156.
  8. Martínez-Bermejo A, Polanco I. Alteraciones neuropsicológicas en la enfermedad celíaca. Rev Neurol. 2002; 34: S24-S33. [CrossRef]
  9. Daynes G. Bread and tears - Naughtiness, depression and fits due to wheat sensitivity. Pro Roy Soc Med. 1956; 49:391-394. [CrossRef]
  10. Cicarelli G, Della Rocca G, Amboni M, Ciacci C, Mazzacca G, Filla A, et al. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci. 2003; 24: 311-317. doi:10.1007/s10072-003-0181-4. [CrossRef]
  11. McAllister BP, Williams E, Clarke K. A comprehensive review of celiac disease/gluten-sensitive enteropathies. Clin Rev Allergy Immunol. 2019; 57: 226-243. doi: 10.1007/s12016-018-8691-2 [CrossRef]
  12. Mirkovic B, Gérardin P. Asperger's syndrome: What to consider? Encephale. 2019; 45: 169-174. doi: 10.1016/j.encep.2018.11.005. [CrossRef]
  13. Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020; 70: 144-156. doi:10.1097/MPG.0000000000002497 [CrossRef]
  14. Saibeni S, Lecchi A, Meucci G, Cattaneo M, Tagliabue L, Rondonotti E, et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol. 2005; 3: 574-580. doi:10.1016/s1542-3565(05)00022-4 [CrossRef]
  15. Sel ÇG, Aksoy E, Aksoy A, Yüksel D, Özbay F. Neurological manifestations of atypical celiac disease in childhood. Acta Neurol Belg. 2017; 117: 719-727. doi:10.1007/s13760-017-0781-z [CrossRef]
  16. Hadjivassiliou M, Aeschlimann P, Sanders DS, Mäki M, Kaukinen K, Grünewald RA, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013; 80: 1740-1745. doi:10.1212/WNL.0b013e3182919070 [CrossRef]
  17. Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics. 2004; 113: 1672-1676. doi:10.1542/peds.113.6.1672 [CrossRef]
  18. Rodrigo Saez L, Lauret-Braña M, Pérez-Martínez I. Manifestaciones extra-intestinales y enfermedades asociadas. Enfermedad Celíaca y Sensibilidad al Gluten No Celíaca. OmniaScience Monograph. Terrassa: Omnia Publisher SL; 2013: 299-323. doi:10.3926/oms.101 [CrossRef]
  19. Kozlowska ZE. Evaluation of mental status of children with malabsorption syndrome after long-term treatment with gluten-free diet (preliminary report). Psychiatr Pol. 1991; 25: 130-134.
  20. San Mauro Martín I, Garicano Vilar E, Collado Yurrutia L. Is gluten the great etiopathogenic agent of disease in the XXI century? Nutr Hosp. 2014; 30: 1203-1210. doi:10.3305/nh.2014.30.6.7866. [CrossRef]
  21. Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q. 2012; 83: 91-102. doi:10.1007/s11126-011-9186-y. [CrossRef]
  22. Pavone L, Fiumara A, Bottaro G, Mazzone D, Coleman M. Autism and celiac disease: Failure to validate the hypothesis that a link might exist. Biol Psychiatry. 1997; 42: 72-75. doi:10.1016/S0006-3223(97)00267-9. [CrossRef]
  23. Ludvigsson JF, Reichenberg A, Hultman CM, et al. A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry. 2013; 11: 1224-1130. doi:10.1001/jamapsychiatry.2013.2048. [CrossRef]
  24. Lau NM, Green PH, Taylor AK, Hellberg D, Ajamian M, Tan CZ, et al. Markers of celiac disease and gluten sensitivity in children with autism. PLoS One. 2013; 8: e66155. doi:10.1371/journal.pone.0066155. [CrossRef]
  25. Ruggieri V. Complicaciones neurológicas de la enfermedad celiaca. Rev Med Hondur. 2014; 82: S74-S78.
  26. Batista IC, Gandolfi L, Nobrega YK, Almeida RC, Almeida LM, Campos Junior D, et al. Autism spectrum disorder and celiac disease: no evidence for a link. Arq Neuropsiquiatr. 2012; 70: 28-33. doi:10.1590/s0004-282x2012000100007. [CrossRef]
  27. Clappison E, Hadjivassiliou M, Zis P. Psychiatric manifestations of coeliac disease, a systematic review and meta-analysis. Nutrients. 2020, 12, 142. doi:10.3390/nu12010142. [CrossRef]
  28. Calderoni S, Santocchi E, Del Bianco T, Brunori E, Caponi L, Paolicchi A, et al. Serological screening for Celiac Disease in 382 pre-schoolers with Autism Spectrum Disorder. Ital J Pediatr. 2016; 42: 98. doi:10.1186/s13052-016-0308-x. [CrossRef]
Newsletter
Download PDF
0 0

TOP